Renal handling of calcium and phosphorus in experimental renal hyperparathyroidism in dogs. 2003

M Belén García-Rodríguez, and Carlos C Pérez-García, and M Angeles Ríos-Granja, and María J Cano-Rábano, and Marina Peña-Penabad, and David Gallego-Morales, and Paulino García-Partida, and Inmaculada Diez-Prieto
Departamento de Medicina Veterinaria, Facultad de Veterinaria, Universidad de León, 24071 León, Spain.

Twenty-four hour urinary excretion, fractional excretion and the filtered load of calcium and phosphorus were monitored as hyperparathyroidism evolved in a model of progressive canine renal failure. Thirteen beagles of both sexes aged four and a half months were used. Nine of them were subjected to a renal damaging schedule (neomycine, 60 mg/kg/48 h, IM, 32 weeks) in order to induce chronic renal failure leading to secondary hyperparathyroidism (2HPT group). The remaining four were kept as the control group. The experiment was conducted over 32 weeks. Blood and 24 h urine were collected every four weeks. Calcium, phosphorus and creatinine were analyzed. Plasma parathormone and calcitonin were determined at weeks 0, 12, 24 and 32. The level of renal function in the 2HPT animals was reduced to 25% of that of the controls (endogenous creatinine clearance was 0.45 +/- 0.22 mL/min/kg as opposed to 1.81 +/- 0.54 mL/min/kg). Hyperparathyroidism was confirmed by a progressive increase in the levels of the parathyroid hormone. Calcitonin levels were not modified. A tendency to hypocalcaemia was observed, reaching statistically significant levels from the twenty-eighth week of the study, when hyperphosphataemia also became significant. Daily urinary excretion of calcium and phosphorus remained at values considered normal throughout the experiment with no alteration imputable to the impaired renal function. This is explained by the decrease in the filtered load of these elements (in both cases statistically significant from the 24th week on) being associated with an increase in their fractional excretion. Thus, calcium and phosphorus urinary excretion values could be maintained in a normal range up to the end of the experiment, showing that renal calcium handling in dogs with experimentally induced renal failure seems to differ from that observed in human patients.

UI MeSH Term Description Entries
D006961 Hyperparathyroidism A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007677 Kidney Function Tests Laboratory tests used to evaluate how well the kidneys are working through examination of blood and urine. Function Test, Kidney,Function Tests, Kidney,Kidney Function Test,Test, Kidney Function,Tests, Kidney Function
D008297 Male Males
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D010758 Phosphorus A non-metal element that has the atomic symbol P, atomic number 15, and atomic weight 31. It is an essential element that takes part in a broad variety of biochemical reactions. Black Phosphorus,Phosphorus-31,Red Phosphorus,White Phosphorus,Yellow Phosphorus,Phosphorus 31,Phosphorus, Black,Phosphorus, Red,Phosphorus, White,Phosphorus, Yellow
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002116 Calcitonin A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults. Thyrocalcitonin,Calcitonin(1-32),Calcitrin,Ciba 47175-BA,Eel Calcitonin,Calcitonin, Eel,Ciba 47175 BA,Ciba 47175BA
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine

Related Publications

M Belén García-Rodríguez, and Carlos C Pérez-García, and M Angeles Ríos-Granja, and María J Cano-Rábano, and Marina Peña-Penabad, and David Gallego-Morales, and Paulino García-Partida, and Inmaculada Diez-Prieto
January 1978, Advances in experimental medicine and biology,
M Belén García-Rodríguez, and Carlos C Pérez-García, and M Angeles Ríos-Granja, and María J Cano-Rábano, and Marina Peña-Penabad, and David Gallego-Morales, and Paulino García-Partida, and Inmaculada Diez-Prieto
January 1973, Pathologia Europaea,
M Belén García-Rodríguez, and Carlos C Pérez-García, and M Angeles Ríos-Granja, and María J Cano-Rábano, and Marina Peña-Penabad, and David Gallego-Morales, and Paulino García-Partida, and Inmaculada Diez-Prieto
October 1964, Acta endocrinologica,
M Belén García-Rodríguez, and Carlos C Pérez-García, and M Angeles Ríos-Granja, and María J Cano-Rábano, and Marina Peña-Penabad, and David Gallego-Morales, and Paulino García-Partida, and Inmaculada Diez-Prieto
January 1961, The American journal of clinical nutrition,
M Belén García-Rodríguez, and Carlos C Pérez-García, and M Angeles Ríos-Granja, and María J Cano-Rábano, and Marina Peña-Penabad, and David Gallego-Morales, and Paulino García-Partida, and Inmaculada Diez-Prieto
January 1993, Journal of applied toxicology : JAT,
M Belén García-Rodríguez, and Carlos C Pérez-García, and M Angeles Ríos-Granja, and María J Cano-Rábano, and Marina Peña-Penabad, and David Gallego-Morales, and Paulino García-Partida, and Inmaculada Diez-Prieto
June 1984, Kidney international,
M Belén García-Rodríguez, and Carlos C Pérez-García, and M Angeles Ríos-Granja, and María J Cano-Rábano, and Marina Peña-Penabad, and David Gallego-Morales, and Paulino García-Partida, and Inmaculada Diez-Prieto
January 2004, Nephrology nursing journal : journal of the American Nephrology Nurses' Association,
M Belén García-Rodríguez, and Carlos C Pérez-García, and M Angeles Ríos-Granja, and María J Cano-Rábano, and Marina Peña-Penabad, and David Gallego-Morales, and Paulino García-Partida, and Inmaculada Diez-Prieto
January 1992, American journal of veterinary research,
M Belén García-Rodríguez, and Carlos C Pérez-García, and M Angeles Ríos-Granja, and María J Cano-Rábano, and Marina Peña-Penabad, and David Gallego-Morales, and Paulino García-Partida, and Inmaculada Diez-Prieto
January 1999, Nephron,
M Belén García-Rodríguez, and Carlos C Pérez-García, and M Angeles Ríos-Granja, and María J Cano-Rábano, and Marina Peña-Penabad, and David Gallego-Morales, and Paulino García-Partida, and Inmaculada Diez-Prieto
June 1978, Federation proceedings,
Copied contents to your clipboard!